Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies

Saved in:
Bibliographic Details
Published inActa Haematologica Vol. 144; no. 3; pp. 246 - 3
Main Authors La Rosée, Felicitas, La Rosée, Paul
Format Journal Article Web Resource
LanguageEnglish
Published Switzerland S. Karger AG 01.05.2021
Subjects
COVID-19
Hematologic Neoplasms - drug therapy
Humans
Nitriles
Pyrazoles - adverse effects
Pyrimidines
SARS-CoV-2
Online AccessGet full text

Cover

More Information
ISSN:1421-9662
DOI:10.1159/000510770